What is Interius BioTherapeutics worth?
$350.0Mlast known valuation
Interius BioTherapeutics last raised $51.4M in its Later Stage VC (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Interius BioTherapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Later Stage VC | $51.4M | ▮ | ▮ |
| Oct 2023 | Debt | $21.5M | ▮ | ▮ |
| May 2021 | Early Stage VC | $43.6M | ▮ | ▮ |
| Mar 2020 | Seed Round | $1.6M | ▮ | ▮ |
How Interius BioTherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Interius BioTherapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Interius BioTherapeutics worth?
- Interius BioTherapeutics's last known valuation is $350.0M.
- How much has Interius BioTherapeutics raised?
- Interius BioTherapeutics has raised $169.6M in total funding across 4 recorded rounds.
- When did Interius BioTherapeutics last raise?
- Interius BioTherapeutics last raised in May 2024 (Later Stage VC), raising $51.4M.